Sarah Cannon Molecular Diagnostics
Healthcare Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Capper Street G/F, London, Greater Lon...Phone Number
+44 2037941920Website
www.sarahcannon-md.co.ukRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Sarah Cannon Molecular Diagnostics
Sarah Cannon Molecular Diagnostics is a research and development company that provides specialized diagnostic testing services for cancer patients. The company utilizes Next Generation Sequencing technology to analyze genetic mutations in tumors, enabling the identification of targeted therapies and clinical trials suited to individual patients. Based in the UK, their diagnostic services help clinicians develop personalized cancer treatment plans by providing detailed insights into oncogenic mutations. The company offers mobile application access to their services and operates across multiple locations, serving both healthcare professionals and patients directly with their advanced molecular diagnostic solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sarah Cannon Molecular Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Sarah Cannon Molecular Diagnostics recently announced quarterly report
Check if Sarah Cannon Molecular Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Sarah Cannon Molecular Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Sarah Cannon Molecular Diagnostics is spiking on competitors!
Click to see if Sarah Cannon Molecular Diagnostics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sarah Cannon Molecular Diagnostics
Product Launch: Get notified when Sarah Cannon Molecular Diagnostics launches new products
Funding: Get notified immidiatlly once Sarah Cannon Molecular Diagnostics has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Sarah Cannon Molecular Diagnostics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Sarah Cannon Molecular Diagnostics
Compare insights from companies similar to Sarah Cannon Molecular Diagnostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sarah Cannon Molecular Di...
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Sarah Cannon Molecular Diagnostics is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Sarah Cannon Molecular Diagnostics is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Sarah Cannon Molecular Diagnostics.
Sarah Cannon Molecular Diagnostics Tech Stack
A closer look at the technologies used by Sarah Cannon Molecular Diagnostics
See more technologies
Top Healthcare Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sarah Cannon Molecular Diagnostics
Sign Up For FreeTo access detailed company insights
Sarah Cannon Molecular Diagnostics is a research and development company that provides specialized diagnostic testing services for cancer patients. The company utilizes Next Generation Sequencing technology to analyze genetic mutations in tumors, enabling the identification of targeted therapies and clinical trials suited to individual patients. Ba... Read More
